A targeted ultrasound contrast agent carrying gene and cell-penetrating peptide: Preparation and gene transfection in vitro

Colloids and Surfaces B: Biointerfaces

Volumn 121, Issue , 2014, Pages 362-370

  Ren, Jianli ^a   Zhang, Ping ^a   Tian, Ju ^a   Zhou, Zhiyi ^a   Liu, Xingzhao ^a   Wang, Dong ^a   Wang, Zhigang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cell penetrating peptide; Gene transfection; Target; Ultrasound contrast agent

Indexed keywords

CELLS; CYTOLOGY; GENE THERAPY; GENE TRANSFER; PEPTIDES; TARGETS; ULTRASONICS;

CELL-PENETRATING PEPTIDE; CELL-PERMEABLE PEPTIDES; CONFOCAL LASER SCANNING MICROSCOPY; GENE TRANSFECTION; HUMAN UMBILICAL VEIN ENDOTHELIAL (HUVEC) CELLS; ISCHEMIC HEART DISEASE; ULTRASOUND CONTRAST AGENT; ULTRASOUND-TARGETED MICROBUBBLE DESTRUCTION; IN-VITRO;

MOLECULAR BIOLOGY; TARGETS;

CELL PENETRATING PEPTIDE; DNA; ECHO CONTRAST MEDIUM; NUCLEASE; PADGEM PROTEIN; PLASMID DNA; CARRIER PROTEIN; MONOCLONAL ANTIBODY; RED FLUORESCENT PROTEIN; ULTRASOUND CONTRAST AGENT CARRIER PROTEIN; UNCLASSIFIED DRUG; CONTRAST MEDIUM; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN;

ARTICLE; CELL HYPOXIA; CONFOCAL LASER MICROSCOPY; DNA BINDING; GENE DELIVERY SYSTEM; GENE LOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; ANTIGEN BINDING; BINDING AFFINITY; BIOACCUMULATION; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CPP GENE; ENCAPSULATION; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE; GENE OVEREXPRESSION; GENE TARGETING; HYPOXIA; IMMUNOFLUORESCENCE MICROSCOPY; MICROBUBBLE; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PEPTIDE ANALYSIS; TARGET CELL; UCA CARRIER GENE; ULTRASOUND TARGETED MICROBUBBLE DESTRUCTION; AMINO ACID SEQUENCE; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MOLECULAR GENETICS; PARTICLE SIZE; PROCEDURES; ULTRASOUND;

AMINO ACID SEQUENCE; CELL HYPOXIA; CELL-PENETRATING PEPTIDES; CONTRAST MEDIA; DNA; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENES; GREEN FLUORESCENT PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; PARTICLE SIZE; TRANSFECTION; ULTRASONICS;

EID: 84905497059     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.06.017     Document Type: Article

References (29)

1. Hedman M., Hartikainen J., Yla-Herttuala S. Progress and prospects: hurdles to cardiovascular gene therapy clinical trials. Gene Ther. 2011, 18:743-749.
2. Giusti I.I., Rodrigues C.G., Salles F.B., Sant'anna R.T., Eibel B., Han S.W., Ludwig E., Grossman G., Prates P.R., Sant'anna J.R., Teixeira Filho G., Markoski M.M., Nesralla I.A., Nardi N.B., Kalil R. High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease. Hum. Gene Ther. Methods 2013, 24:298-306.
3. Albrecht-Schgoer K., Schgoer W., Holfeld J., Theurl M., Wiedemann D., Steger C., Gupta R., Semsroth S., Fischer-Colbrie R., Beer A.G., Stanzl U., Huber E., Misener S., Dejaco D., Kishore R., Pachinger O., Grimm M., Bonaros N., Kirchmair R. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells. Circulation 2012, 126:2491-2501.
4. Azuma J., Taniyama Y., Takeya Y., Iekushi K., Aoki M., Dosaka N., Matsumoto K., Nakamura T., Ogihara T., Morishita R. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther. 2006, 13:1206-1213.
5. Patil S.D., Rhodes D.G., Burgess D.J. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J. 2005, 7:E61-E77.
6. Koren E., Torchilin V.P. Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med. 2012, 18:385-393.
7. Lehto T., Kurrikoff K., Langel Ü. Cell-penetrating peptides for the delivery of nucleic acids. Expert Opin. Drug Deliv. 2012, 9:823-836.
8. Milletti F. Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov. Today 2012, 17:850-860.
9. Hoyer J., Neundorf I. Peptide vectors for the nonviral delivery of nucleic acids. Acc. Chem. Res. 2012, 45:1048-1056.
10. van Asbeck A.H., Beyerle A., McNeill H., Bovee-Geurts P.H., Lindberg S., Verdurmen W.P., Hällbrink M., Langel U., Heidenreich O., Brock R. Molecular parameters of siRNA-cell penetrating peptide nanocomplexes for efficient cellular delivery. ACS Nano 2013, 7:3797-3807.
11. Qi L., Wu L., Zheng S., Wang Y., Fu H., Cui D. Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA. Biomacromolecules 2012, 13:2723-2730.
12. Lehto T., Simonson O.E., Mäger I., Ezzat K., Sork H., Copolovici D.M., Viola J.R., Zaghloul E.M., Lundin P., Moreno P.M., Mäe M., Oskolkov N., Suhorutšenko J., Smith C.I., Andaloussi S.E. A peptide-based vector for efficient gene transfer in vitro and in vivo. Mol. Ther. 2011, 19:1457-1467.
13. Saleh A.F., Aojula H.S., Pluen A. Enhancement of gene transfer using YIGSR analog of Tat-derived peptide. Biopolymers 2008, 89:62-71.
14. Grunwald J., Rejtar T., Sawant R., Wang Z., Torchilin V.P. TAT peptide and its conjugates: proteolytic stability. Bioconjug. Chem. 2009, 20:1531-1537.
15. Koren E., Apte A., Sawant R.R., Grunwald J., Torchilin V.P. Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements. Drug Deliv. 2011, 18:377-384.
16. Tlaxca J.L., Rychak J.J., Ernst P.B., Konkalmatt P.R., Shevchenko T.I., Pizzaro T.T., Rivera-Nieves J., Klibanov A.L., Lawrence M.B. Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease. J. Control. Release 2013, 165:216-225.
17. Li P., Zheng Y., Ran H., Tan J., Lin Y., Zhang Q., Ren J., Wang Z. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice. J. Control. Release 2012, 162:349-354.
18. Meijering B.D., Juffermans L.J., van Wamel A., Henning R.H., Zuhorn I.S., Emmer M., et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ. Res. 2009, 104:679-687.
19. Delalande A1, Kotopoulis S., Postema M., Midoux P., Pichon C. Sonoporation: mechanistic insights and ongoing challenges for gene transfer. Gene 2013, 525:191-199.
20. Li H.L., Du L.F. The study of ultrasound microbubble contrast agent-SonoVue and gene transfection. J. Ultrasound Clin. Med. 2009, 11:37-39.
21. Li X., Wang Z., Ran H., Li X., Yuan Q., Zheng Y., et al. Experimental research on therapeutic angiogenesis induced by Hepatocyte Growth Factor directed by ultrasound-targeted microbubble destruction in rats. J. Ultrasound Med. 2008, 27:453-460.
22. Villanueva F.S., Lu E., Bowry S., Kilic S., Tom E., Wang J., Gretton J., Pacella J.J., Wagner W.R. Myocardial ischemic memory imaging with molecular echocardiography. Circulation 2007, 115:345-352.
23. Kaufmann B.A., Lewis C., Xie A., Mirza-Mohd A., Lindner J.R. Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur. Heart J. 2007, 28:2011-2017.
24. Ren J., Xu C., Zhou Z., Zhang Y., Li X., Zheng Y., Ran H., Wang Z. A novel ultrasound microbubble carrying gene and Tat peptide: preparation and characterization. Acad. Radiol. 2009, 16:1457-1465.
25. Zhou Z., Zhang P., Ren J., Ran H., Zheng Y., Li P., Zhang Q., Zhang M., Wang Z. Synergistic effects of ultrasound-targeted microbubble destruction and TAT peptide on gene transfection: an experimental study in vitro and in vivo. J. Control. Release 2013, 170:437-444.
26. Sanna V., Siddiqui I.A., Sechi M., Mukhtar H. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(d l-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment. Mol. Pharm. 2013, 10:3871-3881.
27. Deng L., Zhang Y., Ma L., Jing X., Ke X., Lian J., Zhao Q., Yan B., Zhang J., Yao J., Chen J. Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells. Int. J. Nanomed. 2013, 8:3271-3283.
28. Smith A.H., Fujii H., Kuliszewski M.A., Leong-Poi H. Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications for angiogenesis. J. Cardiovasc. Transl. Res. 2011, 4:404-415.
29. Li Y.B., Han J.Y., Jiang W., Wang J. Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells. Mol. Biol. Rep. 2011, 38:2301-2306.